The Effect of Cognitive Behavioral Therapy for Insomnia on Type 2 Diabetes Health Outcomes
Insomnia and Type 2 Diabetes: Measurement, Impact and Intervention
1 other identifier
interventional
28
1 country
1
Brief Summary
Insomnia is a common sleep disorder, with three main symptoms: difficulty in initiating sleep, difficulty in maintaining sleep, and/or waking up early without ability to return to sleep. Insomnia can contribute to metabolic dysfunction, which can lead to type 2 diabetes (T2D). Diabetes self-care behavior (DSCB) is important in attaining and maintaining glycemic control, which worsens as a result of fatigue. People with insomnia usually suffer from fatigue and inconstant sleep schedule, which negatively influence quality of life. However, the additive effect of behavioral sleep intervention on diabetes outcomes and health status in people with T2D is unknown. Therefore, The overall purpose of this study is to investigate the impact of both insomnia symptoms and CBT-I on people with T2D. The central hypotheses are that people with T2D and insomnia symptoms will have worse sleep, diabetes measures and self-reported outcomes compared to people with T2D only, which might be adjusted with CBT-I.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2018
CompletedFirst Posted
Study publicly available on registry
October 22, 2018
CompletedStudy Start
First participant enrolled
January 16, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedAugust 28, 2019
August 1, 2019
5 months
October 11, 2018
August 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insomnia Severity Index
The Insomnia Severity Index is a self-report measure designed to evaluate the nature, severity, and impact of insomnia.Seven-items assess severity of sleep onset, sleep maintenance, early morning awakening problems, sleep dissatisfaction, interference of sleep difficulties with daytime functioning, noticeability of sleep problems by others, and distress due to the sleep difficulties.This is self-reported seven items on a five-point Likert scale from zero (not at all satisfied) to four (very much satisfied). Total scores range from 0 to 28, with higher scores indicating greater insomnia severity.
Insomnia severity will be assessed at the baseline and 8 weeks.
Secondary Outcomes (14)
Change in the Variability of Total Sleep Time in Minutes using Objective Measure, Actigraph
The variability of total sleep time for 7 nights will be assessed at the baseline and 8 weeks.
Change in the Variability of Wake after Sleep Onset in Minutes using Objective Measure, Actigraph
The variability of wake after sleep onset for 7 nights will be assessed at the baseline and 8 weeks.
Change in the Variability of Sleep Latency in Minutes using Objective Measure, Actigraph
The variability of sleep latency for 7 nights will be assessed at the baseline and 8 weeks.
Change in the Variability of Sleep Efficiency using Objective Measure, Actigraph
The variability of sleep efficiency for 7 nights will be assessed at the baseline and 8 weeks.
Change in the Variability of Total Sleep Time in Minutes using Subjective Measure, Sleep Diary
The variability of total sleep time for 7 nights will be assessed at the baseline and 8 weeks.
- +9 more secondary outcomes
Study Arms (2)
CBT-I intervention
EXPERIMENTALThe intervention includes several face-to-face interview techniques: sleep restriction therapy, stimulus control procedures, sleep hygiene, relaxation training and cognitive components.
Diabetes Education
ACTIVE COMPARATORSleep hygiene, foot care, causes and diagnosis of diabetes, healthy diet, and physical activity will be delivered for the Health Education group. During all sessions, subjects will be encouraged to engage in the discussion through open questions about their experience in diabetes, lifestyle, and understanding about provided materials.
Interventions
CBT-I is designed to change sleep habits as well as direct misconceptions about sleep and insomnia. Participants will receive several face-to-face interview techniques: sleep restriction therapy, stimulus control procedures, sleep hygiene, relaxation training and cognitive components. The intervention will be provided in 6-session (one session/week).
Participants in this arm will receive education in sleep hygiene, foot care, causes and diagnosis of diabetes, healthy diet, and physical activity. The education will be provided in 6-session (1 session/week).
Eligibility Criteria
You may qualify if:
- Age between 40 to 75 years
- Self-reported diagnosis of type 2 diabetes
- Insomnia Severity Index \>10 and self-reported symptoms of insomnia at least 3 nights/week for the past 3 months for insomnia and type 2 diabetes group
- Insomnia Severity Index ≤10 for type 2 diabetes only group
- Able to attend 6 sessions
- Able to understand and follow verbal commands in English
- Able to travel to our lab
You may not qualify if:
- Self-reported neurological diseases (e.g. Alzheimer's disease, Parkinson's disease, Traumatic Brain Injury, Stroke, Multiple Sclerosis)
- Stop-Bang \> 4 indicating severe risk of sleep apnea
- Failure to pass Restless Leg Syndrome Diagnostic Index
- Severe pain ≥ 7 out of 10 on Brief Pain Inventory
- Severe symptom level of depression scores ≥ 21 on Beck Depression Inventory
- Severe symptom level of anxiety scores ≥ 15 on Generalized Anxiety Scale-7
- Pregnant women
- Self-reported following medical issues: Chronic Fatigue Syndrome, Fibromyalgia, and Rheumatic Diseases
- Speech deficits or significant auditory impairment
- Night-shift work
- Self-reported Bipolar and Seizure Disorders
- Heavy alcohol drinker (≥15 drinks per week for men and ≥ 8 drinks per week for women)
- Dialysis/blindness/trans-femoral amputation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Related Publications (2)
Alshehri MM, Alothman SA, Alenazi AM, Rucker JL, Phadnis MA, Miles JM, Siengsukon CF, Kluding PM. The effects of cognitive behavioral therapy for insomnia in people with type 2 diabetes mellitus, pilot RCT part II: diabetes health outcomes. BMC Endocr Disord. 2020 Sep 5;20(1):136. doi: 10.1186/s12902-020-00612-6.
PMID: 32891140DERIVEDAlshehri MM, Alenazi AM, Hoover JC, Alothman SA, Phadnis MA, Rucker JL, Befort CA, Miles JM, Kluding PM, Siengsukon CF. Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2019 Dec 19;8(12):e14647. doi: 10.2196/14647.
PMID: 31855189DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair, Department of Physical Therapy and Rehabilitation Science
Study Record Dates
First Submitted
October 11, 2018
First Posted
October 22, 2018
Study Start
January 16, 2019
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
August 28, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- The protocol will be submitted to an open access journal and will be available to everyone.
The protocol of this study will be published. We already submit the protocol to an Open access journal.